PortfoliosLab logo

Catalyst Pharmaceuticals, Inc. (CPRX)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$7.06
  • Year Range$4.85 - $8.57
  • EMA (50)$7.50
  • EMA (200)$6.80
  • Average Volume$1.21M
  • Market Capitalization$711.24M

CPRXShare Price Chart


Chart placeholderClick Calculate to get results

CPRXPerformance

The chart shows the growth of $10,000 invested in Catalyst Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $115,738 for a total return of roughly 1,057.38%. All prices are adjusted for splits and dividends.


CPRX (Catalyst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CPRXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-16.84%-12.57%
YTD4.28%-18.14%
6M-3.29%-17.07%
1Y26.98%-5.21%
5Y27.20%10.37%
10Y24.33%11.49%

CPRXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CPRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Catalyst Pharmaceuticals, Inc. Sharpe ratio is 0.49. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


CPRX (Catalyst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CPRXDividend History


Catalyst Pharmaceuticals, Inc. doesn't pay dividends

CPRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CPRX (Catalyst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CPRXWorst Drawdowns

The table below shows the maximum drawdowns of the Catalyst Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Catalyst Pharmaceuticals, Inc. is 90.33%, recorded on May 17, 2016. It took 739 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.33%Jul 23, 2015207May 17, 2016739Apr 25, 2019946
-80.35%Apr 16, 2010650Nov 12, 2012198Aug 27, 2013848
-64.87%Sep 12, 2019128Mar 16, 2020424Nov 17, 2021552
-61.06%Oct 4, 201329Nov 13, 2013202Sep 4, 2014231
-55.81%May 7, 20193May 9, 201971Aug 20, 201974
-35.9%Mar 20, 201529Apr 30, 201550Jul 13, 201579
-30.7%Sep 8, 201427Oct 14, 201473Jan 29, 2015100
-28.72%Nov 18, 202148Jan 27, 202211Feb 11, 202259
-25.5%Jan 15, 201015Feb 5, 201010Feb 22, 201025
-24.7%Feb 23, 20104Feb 26, 201030Apr 12, 201034

CPRXVolatility Chart

Current Catalyst Pharmaceuticals, Inc. volatility is 62.49%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CPRX (Catalyst Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with Catalyst Pharmaceuticals, Inc.


Loading data...

More Tools for Catalyst Pharmaceuticals, Inc.